When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HGEN - Dosing underway in lenzilumab late-stage study in COVID-19
Humanigen Inc.
Humanigen ([[HGEN]] +6.4%) has announced treatment of its first COVID-19 patient with lenzilumab in Phase 3 trial, at MedStar Washington Hospital Center, one of 18 sites in the U.S. approved to enroll eligible patients to study lenzilumab, designed specifically to cytokine storm (harmful inflammation).The primary objective of the trial is to determine if lenzilumab can help hospitalized patients with COVID-19 recover faster.